Industry Report Cites Cost Savings Of Drug-Resistant Infection Screening
This article was originally published in The Gray Sheet
Executive Summary
More frequent testing of patients for drug-resistant infections could improve health outcomes and save billions of dollars, according to a new study sponsored by the device industry